Charlotte Kirby Charlotte Kirby

Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board

Monument Therapeutics, a precision neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership appointments. Robert S. Radie (Bob) has been appointed Non Executive Chair of the Board, effective immediately, and Dr Heather Preston has joined the company’s advisory Board.

Read More
Charlotte Kirby Charlotte Kirby

Sphere Fluidics rebrands to Sphere Bio

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

Read More
Charlotte Kirby Charlotte Kirby

FLIT to ramp up electric bike production as investors pump in £1.2m

Cambridge-based FLIT, an engineering company that builds folding electric bikes for urban commuters, has raised £1.2 million in new funding. The cash injection will be used to scale up production of its latest model, the FLIT M2 at the company’s Cambridge facility.

Read More
Charlotte Kirby Charlotte Kirby

Qureight and Avalyn launch strategic partnership in progressive pulmonary fibrosis

Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat life-threatening pulmonary diseases, have announced the initiation of a strategic partnership in progressive pulmonary fibrosis.

Read More